John Monahan (John James Monahan) is an Irish-born biochemist and CEO of biotechnology and gene therapy companies in the United States.
Education edit
Monahan is from County Kildare in Ireland and was educated at Newbridge College, where he was the inaugural winner of the BT Young Scientist & Technology Exhibition in 1965, his project was an explanation of the process of digestion in the human stomach.[1][2]
He holds a Bachelor of Science from University College Dublin and a PhD in Biochemistry from McMaster University in Ontario, Canada.[3]
Work and research edit
Monahan founded Avigen Inc in Alameda, California a company which became a leader in its sector for the development of pharmaceutical products for the treatment of serious human disease, and raised over $235 million USD through its initial public offering on the NASDAQ stock exchange.[4]
He has directed a number of preclinical and clinical trials and led biotech and pharmaceutical research programmes.[3]
He is current executive vice president research & development for Synthetic Biologics and sits on the scientific advisory board of Agilis Biotherapeutics, LLC.[5]
Monahan also sits on the board of directors at IdentiGEN, the Irish-based DNA analysis company.[4]
References edit
- ^ "Key facts". BT Young Scientist & Technology Exhibition. Retrieved 12 June 2016.
- ^ Kennedy, John (10 January 2014). "Interview with the first-ever young scientist exhibition winner (video)". Silicon Republic. Retrieved 12 June 2016.
- ^ a b "John Monahan Ph.D." Bloomberg. Retrieved 12 June 2016.
- ^ a b "IdentiGEN Appoints Biotech Entrepreneur Dr. John Monahan to Board of Directors". IdentiGEN Ltd. Retrieved 12 June 2016.
- ^ "Dr. John Monahan, a Veteran in Biotechnology and Gene Therapy Companies, Joins the lllScientific lllAdvisory llllBoard of Agilis Biotherapeutics". Business Wire. 3 June 2014. Retrieved 19 December 2021 – via BusinessWire.